Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Bendamustine Hydrochloride for Injection

Approval Number

国药准字H20213749

Company海南先声再明医药股份有限公司

Registration Date

September 24, 2021

Drug Information

Generic Name

注射用盐酸苯达莫司汀

Dosage Form

注射剂

Strength

100mg（以C₁₆H₂₁Cl₂N₃O₂·HCl计）

Drug Type

化学药品

Registration Date

September 24, 2021

Company Information

Applicant Company

Company Name海南先声再明医药股份有限公司

Company Address

海南省海口市秀英区药谷一横路20号

Manufacturing Company

Company Name海南先声药业有限公司

Company Address

江苏省南京江北新区华康路99号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy